BVXV - BiondVax regains Nasdaq compliance
- BiondVax Pharmaceuticals ( NASDAQ: BVXV ) has regained compliance with Nasdaq regarding minimum stockholders’ equity and minimum bid price.
- The company previously reported on Sept. 30, 2022, and Nov. 2, 2022, receipt of the respective non-compliance notifications.
For further details see:
BiondVax regains Nasdaq compliance